EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence

Lisa Padroni, Laura De Marco, Lucia Dansero iD, Valentina Fiano, Lorenzo Milani iD, Paolo Vasapolli, Luca Manfredi, Saverio Caini iD, Claudia Agnoli, Fulvio Ricceri iD, Carlotta Sacerdote iD

International Journal of Molecular Sciences · 15.02.2023 · 24 (4) · 3910

DOI: 10.3390/ijms24043910 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.02.2023. Verfasst von Lisa Padroni und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Via Santena 7, 10126 Turi…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Breast Neoplasms, Circulating MicroRNA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Minister of health, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is a multifactorial disease caused by an interaction between genetic predisposition and environmental exposures. MicroRNAs are a group of small non-coding RNA molecules, which seem to have a role either as tumor suppressor genes or oncogenes and seem to be related to cancer risk factors. We conducted a systematic review and meta-analysis to identify circulating microRNAs related to BC diagnosis, paying special attention to methodological problems in this research field. A meta-analysis was performed for microRNAs analyzed in at least three independent studies where sufficient data to make analysis were presented. Seventy-five studies were included in the systematic review. A meta-analysis was performed for microRNAs analyzed in at least three independent studies where sufficient data to make analysis were presented. Seven studies were included in the MIR21 and MIR155 meta-analysis, while four studies were included in the MIR10b metanalysis. The pooled sensitivity and specificity of MIR21 for BC diagnosis were 0.86 (95%CI 0.76–0.93) and 0.84 (95%CI 0.71–0.92), 0.83 (95%CI 0.72–0.91) and 0.90 (95%CI 0.69–0.97) for MIR155, and 0.56 (95%CI 0.32–0.71) and 0.95 (95%CI 0.88–0.98) for MIR10b, respectively. Several other microRNAs were found to be dysregulated, distinguishing BC patients from healthy controls. However, there was little consistency between included studies, making it difficult to identify specific microRNAs useful for diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBreast NeoplasmsCirculating MicroRNAFemaleHumansIncidence

Stichwörter der Autor:innen

bloodbreast cancermiRNAmicroRNAplasmaserum

Substanzen

Biomarkers, TumorCirculating MicroRNA

Autor:innen und Institutionen

  • Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Via Santena 7, 10126 Turin, Italy.
  • Centre for Biostatistics, Epidemiology and Public Health (C-BEPH), Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
  • Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.
  • Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
  • Unit of Epidemiology, Regional Health Service ASL TO3, 10095 Grugliasco, Italy.

ORCID-Profile: Lucia Dansero, Lorenzo Milani, Saverio Caini, Fulvio Ricceri, Carlotta Sacerdote

Förderung

  • Italian Minister of health
  • Italian Ministry of Health

Zitieren

APA

Padroni, L., De Marco, L., Dansero, L., Fiano, V., Milani, L., Vasapolli, P., Manfredi, L., Caini, S., Agnoli, C., Ricceri, F., & Sacerdote, C. (2023). An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence. International Journal of Molecular Sciences, 24(4), 3910. https://doi.org/10.3390/ijms24043910

Vancouver

Padroni L, De Marco L, Dansero L, Fiano V, Milani L, Vasapolli P, et al. An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence. International Journal of Molecular Sciences. 2023;24(4):3910. doi:10.3390/ijms24043910

BibTeX
@article{Padroni2023,
  author = {Padroni, Lisa and De Marco, Laura and Dansero, Lucia and Fiano, Valentina and Milani, Lorenzo and Vasapolli, Paolo and Manfredi, Luca and Caini, Saverio and Agnoli, Claudia and Ricceri, Fulvio and Sacerdote, Carlotta},
  title = {An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3910},
  doi = {10.3390/ijms24043910}
}
Kostenlos starten →